Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15010 total
DraftKings has dropped 13% over the past month to $25.21, yet the Street is quietly lifting its targets — a split worth unpacking heading into August earnings. The analyst move this week is the standout. JP Morgan's…
ANNX enters the week with a sharp tension at its core: an analyst just doubled his price target while short sellers have quietly built one of the more substantial short positions in small-cap biotech. The most striking…
BILL heads into the back half of July with a story that has two distinct tempos — a stock up 25% over the past month, and a short position that remains among the highest in the application software sector. Short…
Sprout Social heads into its August 6 earnings date with a notable contradiction at its core: the stock is up 16% over the past month, yet shorts have been rebuilding aggressively this week. The short-interest story is…
Progyny enters its August 6 earnings window with an unusual combination: a stock up 21% over the past month, a wall of analyst upgrades behind it, and options traders showing a rare spike in defensive positioning — all…
10x Genomics has flipped the script in one week — the stock is up 21% to $45.79, shorts are actively covering, and the rally has now blown past every analyst price target on the Street. The most striking development is…
BX reports Q2 results on July 17 with short sellers having added meaningful positions over the past month — yet the borrow market and options desk are telling a notably different story from the short-side tape. The…
Dynatrace heads into its August 10 earnings date with one of the more bullish analyst backdrops in the application software space — and a stock that has only just begun to price it in. The analyst story is the standout…
CrowdStrike delivered one of its sharpest single-day moves of the year on Tuesday — up 12% to $210.73 — and the interesting story is not the rally itself but what happened around it: short interest barely budged,…
UBER heads into its August 4 results with options markets flashing an unusually defensive signal — even as short sellers remain a minor presence and the borrow market stays firmly loose. The clearest tension this week…
Palomar Holdings is digesting a 6% pullback this week after its blistering 34% one-month run, with options traders now showing the most defensive tilt in recent memory even as Piper Sandler lifts its target to…
FOXA enters the week carrying one of the most striking short-interest builds in the media sector — nearly 20% of the free float now sold short, up 34% in a single week and 42% over the past month, while the stock has…
DELL has added nearly 10% in a week and 16% over the past month, closing at $457.54 — and the more telling development is that short sellers are accelerating their exit rather than fading the rally. Short interest has…
CI has extended its recovery to $303.35, up nearly 6% on the week, and the underlying data now tells a cleaner bullish setup than it did seven days ago — with shorts continuing to exit and options traders holding their…
Allogene Therapeutics enters the back half of July with a striking contradiction at its core: short sellers are piling in aggressively even as the Street maintains a bullish consensus on the company's Phase 3 cema-cel…
Bloom Energy partially retraced last week's 11% drop, adding 4.2% on Tuesday to close at $243.40 — but the more remarkable shift this week happened in the lending market, where short sellers cut their positions by…
XLC, the Communication Services Select Sector SPDR ETF, is now in the second consecutive week of an accelerating short unwind — and this week the data moved faster than the previous note anticipated. The short retreat…
Amneal Pharmaceuticals enters the week with a fresh analyst upgrade pulling against a softening price, just fifteen days before its next earnings print. The most notable development is on the Street. UBS raised its…
Goosehead Insurance has reversed sharply since the prior note, shedding 9.5% on the week and 8.3% on Tuesday alone — yet short sellers have barely moved, and analysts are raising targets into the weakness. The pullback…
SPOT heads into its Q2 report on July 21 with short sellers retreating sharply and the Street trimming targets despite keeping bullish ratings — a setup that captures the tension between strong fundamental conviction…
